Lv5
938 积分 2024-09-18 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
5个月前
已完结
A pooled analysis of datopotamab deruxtecan in patients with EGFR–mutated NSCLC
5个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
5个月前
已完结
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
8个月前
已完结